Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.750 | 2.750 | 0.000 |
Shares | 97.250 | 97.250 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 35.853 | 15.177 |
Price to Book | 3.862 | 1.957 |
Price to Sales | 3.489 | 1.258 |
Price to Cash Flow | 25.013 | 8.714 |
Dividend Yield | 0.145 | 2.084 |
5 Years Earnings Growth | 16.679 | 12.983 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 42.690 | 11.684 |
Technology | 25.810 | 16.024 |
Industrials | 8.100 | 20.968 |
Financial Services | 7.670 | 11.604 |
Communication Services | 5.650 | 4.425 |
Consumer Defensive | 5.110 | 5.649 |
Consumer Cyclical | 4.420 | 15.324 |
Basic Materials | 0.550 | 6.475 |
Number of long holdings: 75
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alnylam | US02043Q1076 | 8.16 | 268.95 | -3.88% | |
MarketAxesss | US57060D1081 | 5.09 | 271.63 | -0.95% | |
STAAR Surgical | US8523123052 | 4.10 | 29.02 | -4.60% | |
Novocure Ltd | JE00BYSS4X48 | 3.77 | 17.82 | -2.03% | |
EXACT Sciences | US30063P1057 | 3.70 | 50.16 | -2.28% | |
Axon Enterprise | US05464C1018 | 3.57 | 595.18 | -3.40% | |
Ocado | GB00B3MBS747 | 3.41 | 331.70 | -3.44% | |
Zillow C | US98954M2008 | 2.66 | 74.35 | -1.90% | |
Genmab | DK0010272202 | 2.58 | 1,578.0 | -1.93% | |
Blackline | US09239B1098 | 2.34 | 61.15 | -2.19% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BYQG5606 | 4.54B | 9.91 | 6.00 | - | ||
IE00BD1DSB51 | 4.54B | 9.75 | 5.09 | - | ||
IE00BK70ZP28 | 1.39B | 3.05 | 13.44 | - | ||
IE00B8HW2209 | 231.19M | 7.67 | -15.89 | - | ||
IE00BGGJJ945 | 20.26M | -2.35 | 4.05 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review